Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism

Molecular Biology of the Cell
Nabendu PoreAmit Maity

Abstract

Increased expression of vascular endothelial growth factor (VEGF) contributes to the growth of many tumors by increasing angiogenesis. Although hypoxia is a potent inducer of VEGF, we previously showed that epidermal growth factor receptor amplification and loss of PTEN, both of which can increase phosphatidylinositol-3-kinase (PI3K) activity, increase VEGF expression. Using both adenoviral vectors and a cell line permanently expressing constitutively active myristoylated Akt (myrAkt), we show that activation of Akt, which is downstream of PI3K, increases VEGF expression in vitro and increases angiogenesis in a Matrigel plug assay. Transient transfection experiments using reporter constructs containing the VEGF promoter showed that up-regulation of VEGF by Akt is mediated through Sp1 binding sites located in the proximal promoter. Small interfering RNA directed against Sp1 prevented the induction of VEGF mRNA in response to myrAkt but not to hypoxia. Expression of myrAkt is associated with increased phosphorylation of Sp1 and its increased binding to a probe corresponding to the -88/-66 promoter region. In conclusion, our results indicate that Sp1 is required for transactivation of the VEGF by Akt. Others have proposed that the...Continue Reading

References

Dec 1, 1993·The Journal of Clinical Investigation·M C NehlsF Herrmann
Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·A J UdvadiaJ M Horowitz
Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A J UdvadiaJ M Horowitz
Sep 1, 1996·Molecular and Cellular Biology·J A ForsytheG L Semenza
Feb 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·J L ArbiserJ Folkman
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·T C HeB Vogelstein
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·X WuC L Sawyers
Mar 17, 1999·International Journal of Cancer. Journal International Du Cancer·M M FeldkampA Guha
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·L C Cantley, B G Neel
Aug 10, 1999·Nature·W C HahnR A Weinberg
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·B H JiangP K Vogt
Jul 19, 2000·The Journal of Biological Chemistry·S WankhadeP Kannan
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·S WenD L Durden
Jun 26, 2001·Journal of Cellular Physiology·A R BlackJ Azizkhan-Clifford
Sep 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·J R Testa, A Bellacosa
Jun 18, 2002·The Journal of Biological Chemistry·Chandan K SenSashwati Roy
Jun 27, 2002·Neuro-oncology·Christiane B KnobbeGuido Reifenberger
Jul 3, 2002·Nature Reviews. Cancer·Igor Vivanco, Charles L Sawyers
Nov 30, 2002·Expert Opinion on Investigational Drugs·Paul W ManleyJeanette M Wood
Jan 2, 2003·Annals of Neurology·Candelaria Gomez-ManzanoW K Alfred Yung
Jun 5, 2003·Nature Reviews. Cancer·Gabriele Bergers, Laura E Benjamin
Sep 4, 2003·The Cancer Journal·Oliver Bögler, Tom Mikkelsen
Sep 6, 2003·Cancer Cell·James B BrugarolasWilliam G Kaelin
May 20, 2004·Cancer Research·Andrew M ArshamM Celeste Simon

❮ Previous
Next ❯

Citations

May 24, 2011·PloS One·Qingding WangB Mark Evers
Jan 10, 2013·PloS One·Jianjun XiongWeidong Li
Dec 11, 2013·PloS One·Shangli LianMark Bix
Aug 7, 2012·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Enza PiccoloStefano Iacobelli
Jul 1, 2005·Molecular Biology of the Cell·Daniela TrisciuoglioDonatella Del Bufalo
Oct 8, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·Munenori TakaokaHiroshi Nakagawa
Nov 11, 2005·Molecular Biology of the Cell·Fang LiuGary D Kao
Jan 20, 2007·BMC Cardiovascular Disorders·Chandrashekhar D KamatMichael A Ihnat
Oct 17, 2007·Molecular and Cellular Biology·Jianhai JiangJianxin Gu
Jun 2, 2006·Science's STKE : Signal Transduction Knowledge Environment·Joseph A Garcia
Jun 19, 2007·Antioxidants & Redox Signaling·Eui Jung MoonMark W Dewhirst
Mar 20, 2013·BMC Cancer·Agnès FiguerasGabriel Capellà
Mar 26, 2014·Expert Opinion on Therapeutic Targets·Kathleen A FitzgeraldCaitriona M O'Driscoll
Jun 5, 2013·Expert Opinion on Investigational Drugs·Qinglei GaoFei Ye
Jan 20, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jill M SiegfriedLaura P Stabile
Jan 21, 2014·Journal of Pediatric Surgery·Carmelle RomainDai H Chung
Nov 14, 2014·The FEBS Journal·Kate Beishline, Jane Azizkhan-Clifford
Apr 5, 2012·Journal of Dermatological Science·Seung-Hyun SongHyuk-Jin Cha
Nov 30, 2006·Neoplasia : an International Journal for Oncology Research·Nabendu PoreAmit Maity
Dec 24, 2015·Frontiers in Cellular Neuroscience·Ai-Sze Ching, Azlina Ahmad-Annuar
Dec 27, 2008·Cellular Signalling·Y Rebecca Chin, Alex Toker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.